Drug Resistance, NeoplasmAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsDrug ResistanceCisplatinEmployer Health CostsDrug Resistance, ViralDoxorubicinDrug Resistance, MultipleCell Line, TumorDrug Resistance, MicrobialChemotherapy, AdjuvantEtoposideDrug Resistance, BacterialNeoplasmsPrescription FeesAntineoplastic Agents, PhytogenicPaclitaxelDrug Screening Assays, AntitumorCell SurvivalApoptosisDrug Delivery SystemsBreast NeoplasmsDrug Resistance, Multiple, BacterialOvarian NeoplasmsFluorouracilTumor Cells, CulturedCombined Modality TherapyTreatment OutcomeDrug Resistance, FungalDose-Response Relationship, DrugCyclophosphamideMicrobial Sensitivity TestsMutationP-GlycoproteinGene Expression Regulation, NeoplasticAnti-Bacterial AgentsCell ProliferationAntitubercular AgentsDisease ResistanceDrug Resistance, Multiple, ViralVascular ResistanceNeoadjuvant TherapyDisease-Free SurvivalLung NeoplasmsTuberculosis, Multidrug-ResistantMethotrexateSurvival AnalysisAnti-HIV AgentsPrognosisNeoplasm StagingDrug Administration ScheduleVinblastineSurvival RateMultidrug Resistance-Associated ProteinsTime FactorsHIV-1AntimalarialsGenotypeAntibiotics, AntineoplasticCarboplatinMolecular Sequence DataHIV ProteaseMycobacterium tuberculosisGenes, MDRTaxoidsATP-Binding Cassette TransportersAntimetabolites, AntineoplasticHIV InfectionsHIV Reverse TranscriptaseIsoniazidR FactorsStreptomycinAntineoplastic Agents, AlkylatingNeoplasm Recurrence, LocalInduction ChemotherapyDeoxycytidineTetracycline ResistancePenicillin ResistanceDrug Resistance, Multiple, FungalTreatment FailureChloroquineTetracyclineCytarabineReverse Transcriptase InhibitorsMitoxantroneOrganoplatinum CompoundsIfosfamideDaunorubicinRifampinBleomycinSequence Analysis, DNAPhenotypeCarcinoma, Non-Small-Cell LungBacterial ProteinsAnthracyclinesPolymerase Chain ReactionNeoplasm MetastasisFollow-Up StudiesParasitic Sensitivity Tests